Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000104778-02-000022
Filing Date
2002-02-15
Accepted
2002-02-15 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 slxp202.txt SC 13G 2421
  Complete submission text file 0000104778-02-000022.txt   4334
Mailing Address
Business Address 150 SOCIAL HALL AVE SALT LAKE CITY UT 84111 8015330777
WASATCH ADVISORS INC /ADV (Filed by) CIK: 0000104778 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231

Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53269 | Film No.: 02550472
SIC: 2834 Pharmaceutical Preparations